Certified by Founder Lodge
Perceptive Advisors
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $100,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.
| Company | Date | Round | Raised |
|---|---|---|---|
 DNAnexus |
June, 09 ,2022 | Unknown | $100,000,000 |
 Kindbody |
March, 03 ,2023 | Unknown | $100,000,000 |
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 AsclepiX Therapeutics |
July, 27 ,2023 | Series A | $10,000,000 |
 Beta Bionics |
September, 04 ,2023 | Series D | $100,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
 Talkiatry |
June, 19 ,2024 | Series C | $130,000,000 |
 INSIGHTEC |
June, 20 ,2024 | Unknown | $150,000,000 |
 Axonis Therapeutics |
October, 31 ,2024 | Series A | $115,000,000 |
 Kardigan |
January, 14 ,2025 | Series A | $300,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
